305 related articles for article (PubMed ID: 17444496)
1. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
Korosi A; Kozicz T; Richter J; Veening JG; Olivier B; Roubos EW
J Comp Neurol; 2007 Jun; 502(6):973-89. PubMed ID: 17444496
[TBL] [Abstract][Full Text] [Related]
2. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
[TBL] [Abstract][Full Text] [Related]
3. Differential responses of corticotropin-releasing factor and urocortin 1 to acute pain stress in the rat brain.
Rouwette T; Klemann K; Gaszner B; Scheffer GJ; Roubos EW; Scheenen WJ; Vissers K; Kozicz T
Neuroscience; 2011 Jun; 183():15-24. PubMed ID: 21463663
[TBL] [Abstract][Full Text] [Related]
4. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.
Tasma Z; Wills P; Hay DL; Walker CS
Pharmacol Res Perspect; 2020 Jun; 8(3):e00595. PubMed ID: 32529807
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
[TBL] [Abstract][Full Text] [Related]
6. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
[TBL] [Abstract][Full Text] [Related]
7. The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.
Lu B; Diz-Chaves Y; Markovic D; Contarino A; Penicaud L; Fanelli F; Clark S; Lehnert H; Cota D; Grammatopoulos DK; Tabarin A
Int J Obes (Lond); 2015 Mar; 39(3):408-17. PubMed ID: 25189177
[TBL] [Abstract][Full Text] [Related]
8. Distribution of corticotropin-releasing factor (CRF) receptor binding in the mouse brain using a new, high-affinity radioligand, [
Tan LA; Vaughan JM; Perrin MH; Rivier JE; Sawchenko PE
J Comp Neurol; 2017 Dec; 525(18):3840-3864. PubMed ID: 28842924
[TBL] [Abstract][Full Text] [Related]
9. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
Oliveira LA; Almeida J; Benini R; Crestani CC
Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gonadotropins by urocortin 2 in gonadotropic tumor LβT2 cells.
Kageyama K; Murasawa S; Niioka K; Otsuka F; Yagi H; Daimon M
Neurosci Lett; 2017 Nov; 660():63-67. PubMed ID: 28851616
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.
Larson AA; Nunez MG; Kissel CL; Kovács KJ
Eur J Neurosci; 2015 Nov; 42(10):2772-82. PubMed ID: 26332847
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
Nozu T; Okumura T
J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ
Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931
[TBL] [Abstract][Full Text] [Related]
14. Relevance of both type-1 and type-2 corticotropin releasing factor receptors in stress-induced relapse to cocaine seeking behaviour.
Gysling K
Biochem Pharmacol; 2012 Jan; 83(1):1-5. PubMed ID: 21843515
[TBL] [Abstract][Full Text] [Related]
15. Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes.
Dermitzaki E; Liapakis G; Androulidaki A; Venihaki M; Melissas J; Tsatsanis C; Margioris AN
PLoS One; 2014; 9(5):e97060. PubMed ID: 24835211
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Nurr-1/Nur77 in corticotropin-releasing factor/urocortin1-induced tyrosinase-related protein 1 gene transcription in human melanoma HMV-II cells.
Watanuki Y; Takayasu S; Kageyama K; Iwasaki Y; Sakihara S; Terui K; Nigawara T; Suda T
Mol Cell Endocrinol; 2013 May; 370(1-2):42-51. PubMed ID: 23416839
[TBL] [Abstract][Full Text] [Related]
17. Orexinergic innervation of urocortin1 and cocaine and amphetamine regulated transcript neurons in the midbrain centrally projecting Edinger-Westphal nucleus.
Emmerzaal TL; vd Doelen RH; Roubos EW; Kozicz T
J Chem Neuroanat; 2013 Dec; 54():34-41. PubMed ID: 23958928
[TBL] [Abstract][Full Text] [Related]
18. The peripheral corticotropin releasing factor family's role in vasculitis.
Zhu C; Li S
Vascul Pharmacol; 2024 Mar; 154():107275. PubMed ID: 38184094
[TBL] [Abstract][Full Text] [Related]
19. Urocortin 1 inhibits guinea pig gallbladder contractility in vitro via corticotropin-releasing factor receptor 2.
Abd El-Aziz SM; Abdel-Wahab BA
Can J Physiol Pharmacol; 2011 Nov; 89(11):783-91. PubMed ID: 22007876
[TBL] [Abstract][Full Text] [Related]
20. A balance theory of peripheral corticotropin-releasing factor receptor type 1 and type 2 signaling to induce colonic contractions and visceral hyperalgesia in rats.
Nozu T; Takakusaki K; Okumura T
Endocrinology; 2014 Dec; 155(12):4655-64. PubMed ID: 25279793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
